Scientists at the University of Virginia School of Medicine are chasing a new way to slow glioblastoma, the deadliest brain ...

From penetrating solid tumors to new success rates for de novo design, the next wave of antibody therapies aims to transform the clinic.

UC Santa Cruz team achieves synthesis of beneficial neurochemical in just two steps, promising to break a bottleneck in drug ...

NLRP3 is a validated anti-inflammatory target that mediates the release of proinflammatory cytokines IL-1β and IL-18, and ISM5059 targets systemic inflammatory conditions by targeting NLRP3 and ...

Antioxidants have been marketed as miracle supplements, touted for preventing chronic diseases and cancers; treating COPD and ...

AbbVie Inc. (NYSE:ABBV) Q4 2025 Earnings Call Transcript February 4, 2026 AbbVie Inc. beats earnings expectations. Reported ...

A novel immune checkpoint vaccine induced antigen-specific food allergy tolerance in mice, preventing anaphylaxis. Learn more.

Cellular findings show Telomir-Zn modulates intracellular metal balance linked to oxidative stress, mitochondrial dysfunction, DNA methylation instability, and genomic integrity-without relying on cyt ...